More about

Genitourinary Cancer

News
June 07, 2021
1 min read
Save

Molecular tumor profiling beneficial in pediatric solid cancers

Molecular tumor profiling beneficial in pediatric solid cancers

Molecular profiling of solid tumors in children and young adults has a significant impact on diagnosis and treatment recommendations, according to results of an interim analysis presented during the virtual ASCO Annual Meeting.

News
June 04, 2021
2 min read
Save

Pembrolizumab after nephrectomy extends DFS in high-risk clear cell renal cell carcinoma

Pembrolizumab after nephrectomy extends DFS in high-risk clear cell renal cell carcinoma

Adjuvant pembrolizumab appeared associated with a significant and clinically meaningful improvement in DFS vs. placebo among patients with clear cell renal carcinoma, according to results of the KEYNOTE-564 trial.

News
May 21, 2021
2 min read
Save

Cervical cancer incidence declines as rates of other HPV-associated cancers rise

Cervical cancer incidence declines as rates of other HPV-associated cancers rise

Incidence of cervical cancer declined as rates of other HPV-associated cancers increased significantly in the U.S. from 2001 to 2017, according to a population-based study of trends presented during the virtual ASCO Annual Meeting.

News
May 15, 2021
1 min read
Save

Fox Chase Cancer Center appoints site director for radiology

Fox Chase Cancer Center appoints site director for radiology

Jordan Anaokar, MD, has been appointed site director for radiology at Fox Chase Cancer Center.

News
May 06, 2021
2 min read
Save

FDA grants priority review to Keytruda-Lenvima combination for kidney, endometrial cancers

FDA grants priority review to Keytruda-Lenvima combination for kidney, endometrial cancers

The FDA granted priority review to pembrolizumab plus lenvatinib for treatment of advanced renal cell carcinoma and advanced endometrial carcinoma, according to the agents’ manufacturers.

News
April 30, 2021
5 min read
Save

FDA panel votes to maintain four of six indications for checkpoint inhibitors under review

FDA panel votes to maintain four of six indications for checkpoint inhibitors under review

The Oncologic Drugs Advisory Committee voted this week to maintain four of six indications for checkpoint inhibitors that have received FDA accelerated approval.

News
April 30, 2021
1 min read
Save

FDA grants priority review to Opdivo as adjuvant treatment of urothelial carcinoma

FDA grants priority review to Opdivo as adjuvant treatment of urothelial carcinoma

The FDA granted priority review to nivolumab for adjuvant treatment of patients with surgically resected, high-risk muscle-invasive urothelial carcinoma, according to the agent’s manufacturer.

News
April 29, 2021
2 min read
Save

Occult brain metastases found in about 4% of patients with advanced kidney cancer

Occult brain metastases found in about 4% of patients with advanced kidney cancer

About 4% of patients with advanced renal cell carcinoma had asymptomatic brain metastases, according to results of a retrospective multi-institutional cohort study published in Journal of the National Comprehensive Cancer Network.

News
April 19, 2021
1 min read
Save

FDA grants priority review to Padcev for advanced urothelial cancer

FDA grants priority review to Padcev for advanced urothelial cancer

The FDA granted priority review to two supplemental biologics license applications for enfortumab vedotin-ejfv in the treatment of locally advanced or metastatic urothelial cancer.

News
April 17, 2021
1 min read
Save

Huntsman Cancer Institute appoints senior director of clinical research innovation

Huntsman Cancer Institute appoints senior director of clinical research innovation

Neeraj Agarwal, MD, has been appointed senior director of clinical research innovation at Huntsman Cancer Institute at University of Utah.

View more